Literature DB >> 1311136

Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties.

H Ghiasi1, R Kaiwar, A B Nesburn, S L Wechsler.   

Abstract

A recombinant baculovirus (vAc-gB1) was constructed which expresses the glycoprotein B (gB) gene of herpes simplex virus type 1 (HSV-1). When Sf9 cells were infected with these recombinant viruses, a protein that was close in size to authentic HSV-1 gB was detected by gB polyclonal antibody. The recombinant gB was found on the membrane of Sf9 cells and was susceptible to tunicamycin, glycosidase F (PNGase F) and partially susceptible to Endo-H. Antibodies raised in mice to this recombinant recognized viral gB and neutralized the infectivity of HSV-1 in vitro. Mice inoculated with the recombinant gB were protected from lethal challenge with HSV-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311136     DOI: 10.1016/0168-1702(92)90087-p

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  25 in total

1.  The Absence of DHHC3 Affects Primary and Latent Herpes Simplex Virus 1 Infection.

Authors:  Shaohui Wang; Kevin R Mott; Marianne Cilluffo; Casey L Kilpatrick; Shoko Murakami; Alexander V Ljubimov; Konstantin G Kousoulas; Sita Awasthi; Bernhard Luscher; Homayon Ghiasi
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain.

Authors:  S Laquerre; S Person; J C Glorioso
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands.

Authors:  Shaohui Wang; Satoshi Hirose; Homayon Ghiasi
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

4.  Coregulatory interactions among CD8α dendritic cells, the latency-associated transcript, and programmed death 1 contribute to higher levels of herpes simplex virus 1 latency.

Authors:  Kevin R Mott; Sariah J Allen; Mandana Zandian; Homayon Ghiasi
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits.

Authors:  A B Nesburn; S Slanina; R L Burke; H Ghiasi; S Bahri; S L Wechsler
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo.

Authors:  Shaohui Wang; Homayon Ghiasi
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

7.  Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits.

Authors:  A B Nesburn; R L Burke; H Ghiasi; S Slanina; S Bahri; S L Wechsler
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.

Authors:  Shaohui Wang; Alexander V Ljubimov; Ling Jin; Klaus Pfeffer; Mitchell Kronenberg; Homayon Ghiasi
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

9.  A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice.

Authors:  Kevin R Mott; Guey-Chuen Perng; Yanira Osorio; Konstantin G Kousoulas; Homayon Ghiasi
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

10.  Structure, function, and intracellular localization of glycoprotein B of herpesvirus simian agent 8 expressed in insect and mammalian cells.

Authors:  M Veit; C Sott; K Borchers; H Ludwig; M F Schmidt
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.